TP53 and hepatocellular carcinoma: Our group explored the antitumor mechanisms of fangchinoline in hepatocellular carcinomas and demonstrated that autophagic cell death is induced by fangchinoline via the p53/sestrin 2/5′ AMP-activated protein kinase signaling pathway in hepatocellular carcinoma cells [145].